Literature DB >> 27848243

Proposed Algorithm for Managing Ibrutinib-Related Atrial Fibrillation.

Alaina Vrontikis, Jessica Carey, Jeffrey A Gilreath, Ahmad Halwani, Deborah M Stephens, John W Sweetenham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27848243

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  8 in total

1.  How I treat cardiovascular complications in patients with lymphoid malignancies.

Authors:  Joerg Herrmann; Kristen B McCullough; Thomas M Habermann
Journal:  Blood       Date:  2022-03-10       Impact factor: 25.476

Review 2.  How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia.

Authors:  Deborah M Stephens; John C Byrd
Journal:  Blood       Date:  2019-01-14       Impact factor: 22.113

Review 3.  Monitoring and Management of Toxicities of Novel B Cell Signaling Agents.

Authors:  Joanna Rhodes; Anthony Mato; Jeff P Sharman
Journal:  Curr Oncol Rep       Date:  2018-04-11       Impact factor: 5.075

Review 4.  Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach.

Authors:  Iris de Weerdt; Suzanne M Koopmans; Arnon P Kater; Michel van Gelder
Journal:  Haematologica       Date:  2017-08-03       Impact factor: 9.941

5.  Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials.

Authors:  Jennifer R Brown; Javid Moslehi; Susan O'Brien; Paolo Ghia; Peter Hillmen; Florence Cymbalista; Tait D Shanafelt; Graeme Fraser; Simon Rule; Thomas J Kipps; Steven Coutre; Marie-Sarah Dilhuydy; Paula Cramer; Alessandra Tedeschi; Ulrich Jaeger; Martin Dreyling; John C Byrd; Angela Howes; Michael Todd; Jessica Vermeulen; Danelle F James; Fong Clow; Lori Styles; Rudy Valentino; Mark Wildgust; Michelle Mahler; Jan A Burger
Journal:  Haematologica       Date:  2017-07-27       Impact factor: 9.941

6.  Management of Atrial Fibrillation in Patients on Ibrutinib: A Cleveland Clinic Experience.

Authors:  Sidra Khalid; Samin Yasar; Aariez Khalid; Timothy Pp Spiro; Abdo Haddad; Hamed Daw
Journal:  Cureus       Date:  2018-05-29

Review 7.  Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia.

Authors:  Joerg Herrmann
Journal:  Nat Rev Cardiol       Date:  2020-03-30       Impact factor: 32.419

Review 8.  Oncocardiology: new challenges, new opportunities.

Authors:  Lars Michel; Dirk Schadendorf; Tienush Rassaf
Journal:  Herz       Date:  2020-11       Impact factor: 1.740
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.